CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, a Melphalan injection for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The company also develops CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with hemat...
Industry: Biotechnology
Sector: Healthcare
Phone: 86 10 6508 6063
Address:
1701-1702, China Central Office Tower 1, No. 81 Jianguo Road Chaoyang District, Beijing, China
